The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Retrospective analysis of the effect of angiotensin receptor blockers and angiotensin converting enzyme inhibitors on the efficacy of anti-PD-1/PD-L1 immunotherapy in patients with advanced cancer.

Jason  Suh

No Relationships to Disclose

John R.  Rutledge

No Relationships to Disclose

Philip Adam  Friedlander

Stock and Other Ownership Interests  - Adverum; allergan; Clovis Oncology; Gilead Sciences; Incyte; Iovance Biotherapeutics; Thermo Fisher Scientific

Consulting or Advisory Role - Castle Biosciences; DBV Technologies; regeneron

Research Funding - Amgen; Idera; Kartos Therapeutics; Merck; Novartis; Regeneron

Travel, Accommodations, Expenses - Castle Biosciences; Regeneron